used in the detection and quantification of the Hepatitis C Virus
hepatitis C "viral load"
HDL % of Total Cholesterol: Understanding a Key Biomarker for Heart Health HDL % of Total Cholesterol is a useful biomarker that provides insight into cardiovascular health by comparing the level of high-density lipoprotein (HDL) to the total amount of cholesterol in your blood. HDL is often referred to as "good" cholesterol because it helps remove excess cholesterol from the bloodstream, transporting it to the liver for excretion. In contrast, higher levels of low-density lipoprotein (LDL), or "bad" cholesterol, can contribute to the buildup of plaque in arteries, increasing the risk of heart disease. What Does HDL % of Total Cholesterol Indicate? The HDL percentage of total cholesterol is calculated by dividing your HDL cholesterol level by your total cholesterol level and multiplying by 100. This percentage reflects the proportion of your total cholesterol that is made up of HDL, which is an important factor in assessing heart disease risk. A higher HDL percentage indicates a greater proportion of protective HDL cholesterol relative to total cholesterol, which is generally associated with a lower risk of heart disease. A lower HDL percentage suggests that a smaller proportion of your cholesterol is protective, potentially indicating a higher risk for cardiovascular problems. Normal Reference Range The ideal range for HDL as a percentage of total cholesterol typically falls between 20-30%. Higher percentages are considered better, as they reflect a healthier balance between HDL and total cholesterol levels: Below 20%: This is generally considered a risk factor for heart disease and other cardiovascular conditions, as it indicates low levels of HDL relative to total cholesterol. 20-30%: This range is generally seen as normal and reflects a good balance of HDL to total cholesterol. Above 30%: This is ideal, as it suggests a high proportion of protective HDL cholesterol. Why is HDL % of Total Cholesterol Important? The HDL percentage offers a more detailed picture of heart health than simply looking at total cholesterol levels alone. While total cholesterol provides an overview of the cholesterol in your blood, understanding the ratio of HDL to total cholesterol helps to gauge the quality of your cholesterol profile. People with a high percentage of HDL are generally at a lower risk of developing cardiovascular diseases, such as coronary artery disease or stroke. HDL is known to help prevent cholesterol from accumulating in the arteries, and thus, a higher HDL percentage supports better cardiovascular outcomes. Factors Affecting HDL % of Total Cholesterol Several factors can influence HDL levels and the overall HDL percentage of total cholesterol, including: Diet: Diets high in saturated fats, trans fats, and refined sugars can lower HDL levels, while healthy fats such as omega-3 fatty acids from fish, nuts, and seeds can boost HDL. Exercise: Regular physical activity is known to increase HDL levels, improving the HDL percentage of total cholesterol. Smoking: Smoking reduces HDL levels, thereby lowering the HDL percentage and increasing the risk of heart disease. Genetics: Genetic factors can influence both HDL and total cholesterol levels, affecting the HDL percentage. Medications: Certain medications, such as statins or fibrates, can impact cholesterol levels and improve the HDL percentage of total cholesterol. How to Improve Your HDL % of Total Cholesterol If your HDL percentage is lower than the desired range, lifestyle changes can help improve it. Some recommendations include: Adopt a heart-healthy diet: Focus on whole grains, fruits, vegetables, lean proteins, and healthy fats. Limiting saturated and trans fats is essential. Exercise regularly: Aerobic activities such as walking, cycling, and swimming can increase HDL levels. Quit smoking: If you smoke, quitting can have an immediate positive impact on your HDL levels. Moderate alcohol consumption: In some cases, moderate alcohol intake (such as a glass of red wine) has been associated with higher HDL levels, though it's important to follow medical guidance on this. Monitoring the HDL % of Total Cholesterol is a valuable tool in assessing cardiovascular health. A higher HDL percentage indicates a more favorable cholesterol profile and a reduced risk of heart disease. By maintaining a healthy lifestyle through proper diet, regular exercise, and smoking cessation, you can help improve your HDL percentage and support long-term heart health.
Lipoprotein Subfraction Disorders: This test identifies 5 subclasses of HDL, 1 is identified as the large HDL subclass. Decreased levels of the large HDL subclass are associated with a 1.8-fold increased risk for CVD. Large HDL particles are functionally associated with an antioxidant, paraoxanase, which may help protect the arterial wall. Contributing Factors: Genetics/demographics: - Genetic predisposition - High triglyceride levels Lifestyle: - High consumption of simple carbohydrates - Overweight or obese - Sedentary lifestyle - Smoking Illness: - Insulin resistance/diabetes mellitus - Liver, kidney, and thyroid disease Drugs: - Nonselective beta blockers, androgens, progestins Treatment Considerations: Dietary/lifestyle intervention: - Avoid simple dietary carbohydrates - Fat weight loss - Regular exercise - Smoking cessation - Omega-3 fish oil Pharmacological intervention: - Nicotinic acid - Nicotinic acid plus statin Statins (minor effect) - Fibrates when triglyceride levels are elevated Disease intervention: - Correct insulin resistance - Control diabetes mellitus References: Kasper D, Fauci A, Hauser S, et al. Harrison’s Principles of Internal Medicine. 19th ed: McGraw-Hill Education. 2015. Mann DL, Zipes DP, Libby P, Bonow RO. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 10th ed: Saunders. 2015. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Saturated fatty acids and risk of coronary heart disease: Modulation by replacement nutrients. Curr Atheroscler Rep. 2010;12:384-390. Page ST, Krauss RM, Gross C, et al. Impact of mifepristone, a glucocorticoid/progesterone antagonist, on HDL cholesterol, HDL particle concentration, and HDL function.J Clin Endocrinol Metab. 2012;97:1598- 1605. Annuzzi G, Rivellese AA, Wang H, et al. Lipoprotein subfractions and dietary intake of n-3 fatty acid: The Genetics of Coronary Artery Disease in Alaska Natives study. Am J Clin Nutr. 2012;95:1315-1322.
another relevant marker of an atherogenic metabolic dysfunction
Most Protective
may be an independent protective factor against arterial stiffness.
often referred to as “good cholesterol”
High-Density Lipoprotein Cholesterol/Triglycerides Ratio
High-density Lipoprotein Particle Number
Helicobacter pylori has been evolving with human beings for well over 50,000 years, since they migrated out of Africa. H. pylori colonization has been implicated in a variety of gastroduodenal diseases including: - gastritis, - gastric cancer, - and duodenal and peptic ulcer. H. pylori has also been detected by stool PCR in cases of: - dyspepsia, - abdominal pain, - and chronic gastrointestinal symptoms. It is infamous for its causal link to ulcers and gastric cancer, which resulted in a Nobel prize awarded to Robin Warren and Barry Marshall in 2005. However, some sources are suggesting its role, at least in part, as a commensal organism. H. pylori may protect its host from certain atopic disorders, as well as other diseases such as: - esophageal cancer reflux, - and obesity. Population data shows that H. pylori virulence varies geographically. It is associated with high rates of cancer in certain regions, but not in others. The difference may lie in H. pylori’s genetics. Host immune status and acid secretion seem to be other important factors contributing to H. pylori’s colonization and pathogenesis. The H. pylori virulence factors that are most well recognized are vacA and cagA. The presence of cagA-positive H.pylori strains has been significantly associated with gastric cancer and peptic ulcer. The gene codes for a type IV secretion system which allows the bacterium to inject the cagA protein into the host cell. Once inside the host’s gastric epithelial cells, cagA can disrupt cell signaling, leading to abnormal proliferation, motility, and changes in the cytoskeleton. These changes to normal cell signaling can initiate cancer. The presence of vacA has been associated with gastric cancer, peptic ulcer, and duodenal ulcer. The vacA gene is present in all strains of H.pylori but is polymorphic, which leads to different levels of vacuolating toxin. VacA toxins interact with certain receptors on host cells, setting off a chain of events including mitochondrial damage, inhibition of T-lymphocytes, and interference of antigen presentation. Numerous papers suggest the clinical utility of PCR testing for H. pylori. Detection of H.pylori in biopsy specimens by PCR has proven superior to other methods. It has shown sensitivity and specificity reaching that of the diagnostic “gold standard,” which is endoscopy with biopsy and urease test. H.pylori genotyping may be useful for resistant H. pylori infections that have failed to respond to triple antibiotic therapy. In one study of RT-PCR, authors stated it was a “highly accurate noninvasive method to detect H. pylori infection in stool and at the same time allows for culture-independent clarithromycin susceptibility testing.” H. pylori may be asymptomatic and require no treatment or only supportive care to improve the intestinal mucosa and gastrointestinal lining. Information on the cagA and vacA genes may help determine whether treating a positive H. pylori result is necessary.
Increased risk of gastrointestinal disorders, neurological disorders, rheumatic diseases, thyroid autoimmunity and lupus